Incannex Healthcare Inc. Shareholders' Equity
Incannex Healthcare Inc. (IXHL) had Shareholders' Equity of $75.23 million as of 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-05-15
- 2026-03-31: Stockholders' Equity Attributable to Parent $75.23M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $73.41M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $77.01M.
- 2025-06-30: Stockholders' Equity Attributable to Parent $13.39M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-03-31 | $75.23M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $73.41M 10-Q · filed 2026-05-15 | |
| 2025-09-30 | $77.01M 10-Q · filed 2026-05-15 | |
| 2025-06-30 | $13.39M 10-Q · filed 2026-05-15 | |
| 2025-03-31 | $7.40M 10-Q · filed 2026-05-15 | |
| 2024-12-31 | $964.00K 10-Q · filed 2026-05-15 | $965.00K 10-Q · filed 2025-02-14 |
| 2024-09-30 | $6.59M 10-Q · filed 2026-05-15 | |
| 2024-06-30 | $11.22M 10-Q · filed 2026-05-15 | |
| 2024-03-31 | $14.14M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $18.87M 10-Q · filed 2025-02-14 | |
| 2023-09-30 | $19.79M 10-Q · filed 2025-02-14 | |
| 2023-06-30 | $20.82M 10-K · filed 2025-09-29 | |
| 2023-03-31 | $24.67M 10-Q · filed 2024-05-15 | |
| 2022-12-31 | $27.91M 10-Q · filed 2024-05-15 | $27.91M 10-Q · filed 2024-02-14 |
| 2022-06-30 | $24.71M 10-K · filed 2024-09-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B |